Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Oncology Center of Excellence

Oncology Center of Excellence

                        Who We Are - Oncology Center of Excellence
          Project Patient Voice


                        OCE Annual Reports
          Project Community Home
          About FDA
          FDA Organization
          Oncology Center of Excellence
          OCE at ASCO Annual Meeting 2023Oncology Center of Excellence OCE at ASCO Annual Meeting 2023
  
  	
    Share
    Post
    Linkedin

    Email
    PrintFDA Oncology Center of Excellence experts will join colleagues in clinical oncology to participate in panel discussions or present research findings during the American Society of Clinical Oncology (ASCO) Annual Meeting, held in Chicago and online June 2-6, 2023. *All times listed are Central Daylight Time.*

**Saturday, June 3**

**1:15-4:15 pm Poster Session: Health Services Research and Quality Improvement**
Title: Real-world response endpoints in patients with mNSCLC treated with chemotherapy across real-world datasets.
Presenter: Collaborators, Friends of Cancer Research
Abstract 6595 | Poster 87
Location: Hall A

**Sunday, June 4**

**8-11 am Poster Session: Lung Cancer—Non-Small Cell Metastatic** 
Title: FDA analysis of toxicity profiles or oral TKIs recently approved for NSCLC based on receipt of prior immune checkpoint inhibitor therapy 
Presenter: Yufan Liu
Abstract 9119 | Poster 107
Location: Hall A

**9:45-11 am Education Session: The Future of Equitable Access to Clinical Trials**
Speakers: Ana Acuña-Villaorduña, 'Lola Fashoyin-Aje, Steven D. Gore
Location: S100BC**ASCO Educational Book:** **Equitable Access to Clinical Trials: How Do We Achieve It?**

**4:15-5 pm Embracing Career Transitions and Professional Growth**   
Panelist: Jennifer Gao
Location: Women’s Networking Lounge S502

**Monday, June 5**

**8-9:15 am Educational Session: Accelerated Approvals in Oncology: Balancing Access with Evidence**
Speakers: R. Angelo De Claro, Andrew James Schorr, Walid Gellad
Location: S102

**8-11 am Poster Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary**
Location: Hall A
Title: FDA analysis of treatment efficacy based on etiology of hepatocellular carcinoma
Presenter: May Tun Saung, MD
Abstract 4117 | Poster 438

Title: Geographical and baseline clinical characteristics of participants enrolled in hepatocellular carcinoma (HCC) trials: Analysis of US FDA approvals
Presenter: Naomi Horiba
Abstract 4115 | Poster 436

**9:45-11:00 am Innovative Solutions to the Challenges of Cancer Clinical Trials: FDA and NCI perspectives**
Location: S100BC
Panelists: Richard Pazdur, Paul Kluetz, Monica Bertagnolli, Julie Gralow, James Doroshow, Sheila Prindiville, Michael Morris

**1:15-4:15 pm Poster Session: Care Delivery and Regulatory Policy**
Location: Hall A
Title: Trends in new and persistent opioid use in older adults with cancer.
Presenter: Collaborators, Yale-Mayo CERSI
Abstract 1592 | Poster 186

Title: Trends in U.S and global patient enrollment from 2014 to 2022 in lung cancer clinical trials supporting marketing applications: An FDA analysis.
Presenter: Oladimeji Akinboro
Abstract 1576 | Poster 170

Title: Dosage Optimization in Drug Development: An FDA Project Optimus analysis of postmarketing requirements Issued to repair the cracks
Presenter: Brian Heiss
Abstract 1598 | Poster 192

**Tuesday, June 6**

**Online only publication: Health Services Research and Quality Improvement Track**

Enrollment representation of age, race, and ethnicity in ovarian cancer registrational clinical trials (2010-2020): An evaluation by the U.S. Food and Drug Administration

Authors: Felice Yang, Yue Huang, Catherine Lerro, Wei Liu, Mallorie Fiero, Zhou Feng, Bindu Kanapuru, Timil Patel, Laleh Amiri-Kordestani, Gwynn Ison, Lola Fashoyin-Aje, Paul Kluetz, Harpreet Singh, Donna Rivera



**Additional Information**

FDA Oncology Center of Excellence
	Upcoming Public OCE Meetings

                                                                                  Content current as of:
      05/26/2023Oncology Center of Excellence

          
                        Who We Are - Oncology Center of Excellence
          Project Patient Voice


                        OCE Annual Reports
          Project Community
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop